JOYTECJOYTEC CREDENTIALSCREDENTIALS QUANT STUDIESQUANT STUDIES2023
DIABETES (KSA) Quantitative study 30-Minutes N=12 Physicians (Insulin prescribers) A chronic condition in which blood glucose levels are high due to the body's inability to produce enough insulin or use it efficiently.
ALOPECIA AND VITILIGO (UAE, KSA, TURKEY) Quantitative study 30-Minutes N=30 Dermatologists closely linked autoimmune conditions In alopecia, the immune system mistakenly attacks hair follicles causing hair loss. In vitiligo, it attacks pigment-producing cells (melanocytes), causing white patches
LEQVIO STUDY (EGYPT, UAE, KSA) Quantitative study 45-Minutes N=35 Cardiologists for Egypt and KSA An injection used to lower bad cholestrol this medication is prescribed for adult patients as an adjunct to diet, and is administered every six months after the first two doses. N=20 for UAE.
FLU VACCINE (KSA & UAE) Quantitative study 60-Minutes N=20 HCPs who administer influenza vaccines to adults A 10-mints follow-up The study aims to test and optimise an unbranded HCP campaign concept in OUS markets, and to support development of resources to support HCPs in handling common concerns or objections from consumers.
MEDIA USAGE (EGYPT) Quantitative study 10-Minutes N=20 cardiologists, dermatologists, haematologists, oncologists and rheumatologists (45-mints) with N=50 per speciality This is about respondents Media usage and other sources of information they may access
RADIATION SAFETY GARMENTS (IRAQ) Quantitative study 30-Minutes N=13 of Procurement team Procurement team in government and private hospitals with radiology labs, Radiation safety officers and Cardiologists and Sales and distributors for radiation safety garments.
HOSPITAL RANKING (UAE) Quantitative study 20-Minutes N=50 hospital specialists and N=50 GPs at Egypt N=25 hospital specialists and N=25 GPs at both KSA & UAE.
ASTHMA (KSA) Patients PRFs N= 40 Patients the study targets newly diagnosed Asthma patients with Mild/Moderate Severity who were diagnosed and initiated treatment between JULY – SEPT 2023 or Exacerbated Mild/Moderate Asthma patients who visited for an Exacerbation between JULY – SEPT 2023.
SCHIZOPHRENIA (SOUTH KOREA, THAILAND, MYANMAR, TURKEY, AND EGYPT) PRF pre-task N= 40 Patients a mix of high prescribers of LAIs (long-acting injectable anti-psychotics), low prescribers of LAIs and non- prescribers of LAIs.
IMMUNE COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (IC-MPGN) AND C3 GLOMERULOPATHY (C3G) (KSA) Quantitative study 15-mints PRFs Research aims to understand how Nephs treat C3G & IC-MPGN currently and what the unmet needs are. N=10 Nephrologists
CONSUMER PANEL (UAE, EGYPT) Quantitative study N=148 Adults
JOYTECJOYTEC CREDENTIALSCREDENTIALS QUANT STUDIESQUANT STUDIES2024
AMD & DME Quantitative study 45-mints online surveys N=20 HCPs including ophthalmologists who must manage and treat AMD and DME patients and must personally prescribe anti-VEGF treatment. The study aims to tracking the performance of EYELA in the AMD and DME space, both original 2mg formulation and the newly launched 8mg formulation
MULTIPLE MYELOMA (ISRAEL) Quantitative study 30 mints with 5 PRFs N=30 Oncologists/Hematologists who Treat a minimum number of MM patients in Stage 2 and higher Our tasks include Scripted survey, Survey links, Data quality checks and Reporting on survey progress.
SICKLE CELL DISEASE (KSA) Quantitative study 45-mints N=10 Transplant specialists (hematologists) who have At least 5 SCD patients treated in past 12 months, and N=10 Non-transplanter, SCD-treating hematologists who have At least 10 SCD patients referred to HSCT (or gene therapy) in past 12 months Our tasks include Scripted survey, Survey links, Data quality checks and Reporting on survey progress.
HOSPITAL RANKING (KSA, UAE, EGYPT) Quantitative study 20-mints N=50 hospital specialists, N=50 GPs at Egypt, N=25 hospital specialists and N=25 GPs at both KSA & UAE.
MULTIPLE MYELOMA (UAE) Quant web survey 45-mints N=15 private and public sector hospitals. 1-2 HCPs per same facility except for few public centres may be 3/same facility.
AUTOMATED BREAST ULTRASOUND (ABUS) (KSA) Quantitative study 20-mints N=15 Radiologists & N=15 Breast Surgeons
OBESITY, WEGOVY (UAE) Quantitative study 30-mints N=35 Obesity treaters (Endos/ Cardios /Obs/ Gyn) & N=35 PCPs.
HODGKIN LYMPHOMA (EGYPT) Quantitative study 20-mints N= 15 Haema- Onco doctors Tasks managed by our team included materials translation, recruitment, interviewing respondents, QC, and data entry.
RETINA STUDY Quantitative study 15-mints KSA with N=30 and UAE with N=20. aimed to understand the size of pool of patients who could potentially be treated (based on numbers around diagnosis/currently seen) with Retina specialists who see/diagnose geographic atrophy (aka dry AMD)
MULTIPLE MYELOMA UAE, KUWAIT AND KSA Quantitative study 50-mints N=25 HCP from UAE + Kuwait and N=20 KSA
AUTOMATED BREAST ULTRASOUND (KSA) Quantitative study 20-mints N=15 Radiologists/Breasts Radiologists and N=15 Breast Surgeons Doctors had 5+ years of experience, see 20+patients undergoing breast cancer screening/diagnosis per month and decision makers.
JOYTECJOYTEC CREDENTIALSCREDENTIALS QUANT STUDIESQUANT STUDIES2025
OTC UAE & EGYPT Quantitative study 20-mints N=75 pharmacists per market. The study aims to measure the success of the campaigns as a proof of concept to encourage significant market investment and to develop an easy, accessible framework to measure success for Haleon stakeholders. It was conducted with pharmacists, a mix of men and women (30-55 years), responsible for recommending pain and respiratory OTC medications.
GASTRIC CANCER MONITOR (UAE) Quantitative study N=20 PRFsThe study aims to capture PRFs from selected hospitals for patients diagnosed with gastric cancer who received treatment between June and October 2024. It targets oncologists/hematologists involved in treating gastric cancer. JOYTEC tasks include recruiting and interviewing doctors, collecting PRFs, and submitting them to the client.
BREAST CANCER (UAE) Quantitative study 30-mints N=10 Medical Oncologists and breast surgeons.
ASCVD AND LP(A) (UAE, KSA, TURKEY, AND INDIA) Quantitative study 30-mints N=50 mixed specialties including Cardiologists, Interventional Cardiologists, Neurologists, and Endocrinologists.
RESISTANT PROSTATE CANCER - JORDAN ATU STUDY Quantitative study 20-mints N=30 oncologists who is Consultant / Senior Consultant with minimum 3 -5 years of experience, have Primary decision in the treatment of prostate cancer and treating a minimum load of prostate cancer and mCRPC patients per month.
OBESITY CONFERENCE (META) Quantitative online survey 20-mints N=5 of Obesity Treaters (Endocrinologists, PCPs, Bariatric Surgeons, Specialist Nurses and Clinical Pharmacists)the study aims to understand their impact at conference (European conference for obesity) and how it establishes them as leaders in obesity. The study was conducted at 2 phases, pre & post-conference.
SICKLE CELL DISEASE (KSA) Quantitative survey 45-mints N=10 of two stakeholder types: Transplant specialists (hematologists) & Non-transplanter, SCD-treating hematologists
HOSPITAL HCPS (UAE) Quantitative survey 20-mints N=50 hospital specialists and N=50 GPs at Egypt, N=25 hospital specialists and N=25 GPs at both KSA & UAE.
AMD & DME Quantitative study 45-mints online surveys N=20 HCPs including ophthalmologists who must manage and treat AMD and DME patients and must personally prescribe anti- VEGF treatment.The study aims to tracking the performance of EYELA in the AMD and DME space, both original 2mg formulation and the newly launched 8mg formulation
JOYTECJOYTEC CREDENTIALSCREDENTIALS QUANT STUDIESQUANT STUDIES2026
ASTHMA AND BRONCHITIS (QATAR, KSA) PRFs study N=150 at Qatar and N=600 at KSA Target audience included PCPs, Pulmonologists and ERs.The study aims to collect PRFs from patients diagnosed with asthma and received treatment between June – November 2025. JOYTEC tasks include recruiting and interviewing doctors, collecting PRFs, and submitting them to the client.
THANK YOU